did-you-know? rent-now

Amazon no longer offers textbook rentals. We do!

did-you-know? rent-now

Amazon no longer offers textbook rentals. We do!

We're the #1 textbook rental company. Let us show you why.

9780803600713

Nuclear Cardiac Imaging Principles and Applications

by ;
  • ISBN13:

    9780803600713

  • ISBN10:

    0803600712

  • Edition: 2nd
  • Format: Hardcover
  • Copyright: 1996-06-01
  • Publisher: Oxford University Press
  • View Upgraded Edition
  • Purchase Benefits
  • Free Shipping Icon Free Shipping On Orders Over $35!
    Your order must be $35 or more to qualify for free economy shipping. Bulk sales, PO's, Marketplace items, eBooks and apparel do not qualify for this offer.
  • eCampus.com Logo Get Rewarded for Ordering Your Textbooks! Enroll Now
List Price: $192.00
We're Sorry.
No Options Available at This Time.

Summary

This is a definitive edited work on the assessment of heart problems through nuclear imaging and exercise testing, now in its second edition. New imaging agents, the shift from planar to SPECT imaging, and greater computer capabilities are all reflected in this completely rewritten volume.Technical aspects are described when necessary.

Table of Contents

Radiopharmaceuticals, Dosimetry, and Tracer Kinetics
1(28)
Part I: An Introduction to Nuclear Medicine
1(4)
Part II: Production of Radionuclides and Radiopharmaceutical Dosimetry
5(5)
Part III: Tracer Kinetics
10(15)
Glossary
25(4)
Instrumentation and Technical Considerations in Planar and SPECT Imaging
29(17)
Imaging Systems
29(4)
Quality Assurance in Cardiac Nuclear Imaging: Detection Efficiency or Sensitivity
33(5)
Digital Computers
38(1)
Applications of Computers in Nuclear Cardiology
39(1)
Thallium 201 Planar Imaging Methodology
40(1)
Technetium 99m Sestamibi Imaging Methodology
41(2)
Technetium 99m Teboroxime Imaging Methodology
43(1)
Principles of Single-Photon Emission Computed Tomography: Acquisition and Processing
43(3)
Exercise Testing and Physiology
46(27)
Exercise Physiology
46(4)
Types of Exercise Tests
50(1)
Exercise Protocols
50(1)
General Considerations for Exercise Testing
51(2)
Interpretation
53(9)
Results of Exercise Testing
62(11)
Exercise Perfusion Imaging in Coronary Artery Disease: Physiology and Diagnosis
73(71)
Anatomic and Physiologic Basis of Cardiac Imaging
74(2)
Methods for Assessing Coronary Blood Flow in Humans
76(2)
Technical Aspects of Exercise Perfusion Scintigraphy
78(3)
Indications for Exercise Perfusion Imaging
81(1)
Diagnosis of CAD by Exercise Scintigraphy
82(50)
Detection of Silent Myocardial Ischemia by Myocardial Perfusion Imaging
132(12)
Radionuclide Angiography
144(75)
Gated Versus First-Pass RNA
145(2)
Ejection Fraction Reliability and Reproductivity
147(10)
Peripheral Circulatory Dynamics
157(1)
Diastolic LV Function
157(10)
Exercise RNA
167(21)
Effect of Drugs on Ventricular Function
188(13)
Simultaneous Assessment of Myocardial Function and Perfusion
201(18)
Pharmacologic Stress Testing and Other Alternative Techniques in the Diagnosis of Coronary Artery Disease
219(23)
Pharmacologic ``Stress'' Myocardial Perfusion Scintigraphy
220(14)
Pharmacologic Stress in Combination with Radionuclide Angiography
234(2)
Atrial Pacing Stress as an Adjunct to Cardiac Radionuclide Imaging
236(1)
Induction of Coronary Vasoconstriction in Combination with Myocardial Perfusion Scintigraphy
236(1)
Cold Pressor Stress as an Adjunct to Myocardial Perfusion Scintigraphy
236(6)
Risk Assessment
242(37)
Background
242(1)
Cardiac Events
243(1)
Clinical Models in Risk Stratification
243(1)
Risk Assessment in Patients with Silent Ischemia
244(1)
Risk Assessment in Patients with Stable Symptoms: Use of Perfusion Imaging
245(9)
Risk Assessment in Patients with Stable Symptoms: Use of Radionuclide Angiography
254(3)
Risk Assessment After Coronary Artery Bypass Surgery and Coronary Angioplasty
257(1)
Risk Assessment After Acute Myocardial Infarction
257(11)
Risk Assessment in Patients with Unstable Angina
268(1)
Risk Assessment Before Major Noncardiac Surgery
269(10)
Nuclear Imaging After Coronary Revascularization
279(26)
Myocardial Perfusion Imaging and Coronary Revascularization
279(18)
Radionuclide Angiography and Coronary Revascularization
297(4)
Use of Radionuclide Imaging in Risk Assessment After Coronary Artery Revascularization
301(4)
Myocardial Viability
305(22)
Hibernation and Stunning
305(2)
Patient Selection for Viability Studies
307(1)
Methods for Detection of Viability
308(11)
Factors Affecting Recovery of LV Function
319(2)
Summary and Perspectives
321(6)
Scintigraphic Techniques in Acute Ischemic Syndromes
327(30)
Infarct-Avid Imaging
327(13)
Myocardial Perfusion Imaging in Acute Myocardial Infarction
340(11)
Thallium 201 and Technetium 99m Sestamibi in Unstable Angina
351(6)
Scintigraphic Imaging in Other Types of Heart Disease
357(49)
Valvular Heart Disease
358(15)
Hypertrophic Cardiomyopathy
373(2)
Other Types of Cardiomyopathies
375(2)
Pericardial Disease
377(1)
Systemic Disorders
377(5)
Congenital Heart Disease
382(4)
Doxorubicin Cardiotoxicity
386(1)
Radiation Therapy
387(1)
Effect of Angiographic Contrast Medium
387(1)
Effect of Intra-aortic Balloon Pumping and Support Devices
388(1)
Tumors
389(2)
Changes in Cardiac Rhythm or Conduction
391(3)
Septic Shock
394(1)
Miscellaneous Conditions
394(12)
Other Nuclear Imaging Modalities
406(15)
Single-Photon Metabolic Imaging
406(4)
Tracers of Cardiac Innervation and Receptors
410(3)
Clot Detection by Imaging Techniques
413(1)
Indium 111-Labeled Lymphocyte Imaging to Detect Cardiac Rejection
413(1)
Atherosclerosis Imaging
414(1)
The Multiwire Gamma Camera
414(3)
Imaging of Tracer-Labeled Ischemia or Hypoxia
417(4)
Alternative Noninvasive Imaging Techniques: Which Test, When, and Why?
421(10)
Comparison of Noninvasive Techniques
421(3)
Diagnosis of CAD
424(1)
Risk Assessment of Patients with CAD
424(3)
Detection of CAD in Patients with Aortic Valve Disease or Hypertrophic Cardiomyopathy
427(1)
Assessment of Cardiotoxicity
427(1)
Detection of Left-to-Right Intracardiac Shunts
427(1)
Detection and Quantitation of Valvular Regurgitation
427(1)
Detection and Localization of Bypass Tracts in Patients with Wolff-Parkinson-White Syndrome
427(1)
Assessment of LV Function and Right Ventricular Function
427(1)
Cost-Effectiveness Analysis
427(4)
Appendix A Laboratory Organization 431(11)
Appendix B Specific Training Requirements for Nuclear Cardiology 442(1)
Index 443

Supplemental Materials

What is included with this book?

The New copy of this book will include any supplemental materials advertised. Please check the title of the book to determine if it should include any access cards, study guides, lab manuals, CDs, etc.

The Used, Rental and eBook copies of this book are not guaranteed to include any supplemental materials. Typically, only the book itself is included. This is true even if the title states it includes any access cards, study guides, lab manuals, CDs, etc.

Rewards Program